Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
33.33
+0.19 (0.57%)
At close: Apr 2, 2026, 4:00 PM EDT
33.13
-0.20 (-0.60%)
After-hours: Apr 2, 2026, 6:32 PM EDT
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $3.58 billion as of April 2, 2026. Its market cap has increased by 52.72% in one year.
Market Cap
3.58B
Enterprise Value
3.05B
1-Year Change
52.72%
Ranking
Category
Stock Price
$33.33
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $3.58B, an increase of 369.77%. That is a compound annual growth rate of 36.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 3.58B | 36.09% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 3.98B |
| Spyre Therapeutics | 3.84B |
| Crinetics Pharmaceuticals | 3.83B |
| Viking Therapeutics | 3.81B |
| ACADIA Pharmaceuticals | 3.81B |
| NewAmsterdam Pharma Company | 3.77B |
| Structure Therapeutics | 3.55B |
| Legend Biotech | 3.52B |